Today’s post is an interview I did with Dr. Van Bokkelen covering 10 questions. Dr. Gil Van Bokkelen is Chairman and CEO of Athersys, Inc., a company that has focused heavily on stem cells and regenerative medicine for more than a decade. For more on Dr. Van Bokkelen’s background see additional bio section at the end of …
One of the more exciting stem cell biotechs out there today is Advanced Cell Technology (ACT). At this time ACT has the only two ES cell-based FDA-approved clinical trials ongoing and so far they have looked quite promising in terms of preliminary safety data. However, ACT has much more in the pipeline including potentially iPS …
Interview with Gary Rabin of Advanced Cell Technology (ACT) Read More »
Yesterday I announced the category 1 (age 18 or younger) winner of my stem cell essay contest. The fascinating topic was what do we become if we start replacing our parts with transplants. Prize? Publication and $50 iTunes gift card. Today I announce the winner of Category 2, Agnes Oshiro of Davis, CA. Congratulations, Agnes. …
Stem Cell Essay Contest Winner Category 2: Agnes Oshiro Read More »
TGIF It’s been a wild week on this blog with many thoughts going out to the future of stem cells in Texas. What about stem cell headlines of the week? Some wildness there too and lots of discussion of translational applications, which is exciting. This week let’s start in reverse order with the ugly and …
TGIF: good, bad, ugly stem cell headlines of week of May 25 Read More »